Strains and vectors for protein expression and secretion have been developed in the yeast Yarrowia lipolytica. Host strains were constructed with non-reverting auxotrophic markers, deletions of protease-encoding genes, and carrying a docking platform. To drive transcription, either the synthetic hp4d or the inducible POX2 promoter were used. Protein secretion is either directed by the targeting sequence of the alkaline extracellular protease or the extracellular lipase (LIP2p) signal sequence. We describe a set of vectors based on these promoters, targeting sequences and two URA3 alleles as selection markers. The wild-type URA3 allele, ura3d1, was used for singlecopy integration and a mutant URA3 allele, ura3d4, was used to select for multi-copy integration into the genome. These vectors were used to express the Y. lipolytica extracellular lipase LIP2p and the Aspergillus oryzae leucine amino peptidase II. Lipase production under the control of the hp4d promoter by a strain containing a single copy reached 1000 U ml 31 in shake flasks, while a strain containing multiple integrations reached 2000 U ml 31 in shake flasks, 11 500 U ml 31 in batch and 90 500 U ml 31 in fed batch. Leucine amino peptidase production under the control of the hp4d promoter reached 320 mU ml 31 in batch with a mono-copy lapA integrant and 28 000 mU ml 31 in fed batch with a multi-copy transformant. ß
Introduction
The optimisation of heterologous gene expression is of great importance for the industrial production of proteins for pharmaceutical or technical applications. Yeast expression systems combine the ease of manipulation and growth of unicellular organisms with eukaryotic post-translational processing and modi¢cations. The application of Saccharomyces cerevisiae as a host for heterologous production has shown a number of limitations (low production of secreted proteins, limited number of signal sequences available, biomass yield decreased by ethanol formation). A number of 'non-conventional' yeasts have been studied since several years. In addition to the well-known Pichia pastoris, these alternative yeasts include Schizosaccharomyces pombe, Hansenula polymorpha, Kluyveromyces lactis, Schwanniomyces occidentalis and Yarrowia lipolytica (reviewed in [1, 2] ). Among these, Y. lipolytica was found to be one of the most attractive host organisms [3] .
Y. lipolytica is a dimorphic yeast that naturally secretes several enzymes such as proteases, lipases, esterases and RNase [4] . Among them, alkaline extracellular protease (AEP) could reach several grams per litre under optimised conditions [4] . This yeast was used in industrial applications such as the production of single-cell proteins, peach £avour or citric acid (process classi¢ed as GRAS^gen-erally regarded as safe^by the American Food and Drug Administration), thus permitting the accumulation of extensive data on its behaviour in fermenters [5] . Its range of natural substrates includes alkanes, fatty acids, organic acids and proteins, but relatively few sugars (mainly glucose); it has been extended to include saccharose and molasses [6] . The large number of genetic markers and molecular tools available in this yeast [3,4,7^10] allowed us to develop an e⁄cient heterologous protein production system. Strains Po1d, Po1e, Po1f, Po1g and YLP21 were derived from the wild-type strain W29 [4, 7] (Table 1) by disruption of the URA3 gene with the S. cerevisiae SUC2 gene (allele ura3-302) [6] , followed by the introduction of a deletion in the LEU2 gene (StuI deletion, allele leu2-270) by a pop in/pop out event. Deletion of the XPR2 gene, encoding the AEP, gave rise to strain Po1d (allele xpr2-322). Deletion of the AXP gene, encoding the acidic protease, gave rise to strain Po1f. Po1e and Po1g were obtained by transformation of Po1d and Po1f, respectively, with a pBR322-URA3 vector, forming a docking platform to direct integration of the pBR322-based expression/secretion vectors. YLP21 is a LEU2-prototrophic derivative of Po1f, in which a ApaI-linearised JMP21 plasmid (a pHSS6-derived plasmid carrying the wild-type LEU2 gene) was integrated.
Several secretion signals were described in Y. lipolytica. AEP is synthesised as a prepro protein with a short presequence (13 amino acids) followed by a stretch of 10 dipeptides (motif X-Ala or X-Pro) and a large proregion (122 amino acids) ending with a Lys-Arg motif [11] , the substrate of the KEX2 like endoprotease encoded by the XPR6 gene [12] . This proregion contains a glycosylation site and was shown to act as an internal chaperone for AEP secretion [13, 14] . Initially, the XPR2 secretion signal was used for heterologous protein secretion and patented by the P¢zer company [15] . Recently, the secretion signal of the extracellular lipase encoded by the LIP2 gene was identi¢ed [16] . It presents features similar to those of the XPR2 signal: a short presequence (13 amino acids) followed by four dipeptides X-Ala/X-Pro, a short proregion (10 amino acids) and a LysArg cleavage site.
The XPR2 promoter, although strong, is only active at pH above 6 on media lacking preferred carbon and nitrogen sources. Additionally, the XPR2 promoter requires high levels of peptones in the culture medium for full induction [17] . To circumvent these problems, the synthetic promoter hp4d was developed [8] . It is composed of four direct tandem copies of the upstream activating sequence 1 (UAS1 region) from the XPR2 promoter, cloned upstream of a minimal LEU2 promoter. The transcription activity of the hp4d promoter is as high as that of the fully induced XPR2 promoter. Moreover, hp4d is not repressed by carbon or nitrogen sources nor does it require peptones for induction [8] . Muller and collaborators [3] isolated and used the promoter regions of the translation elongation factor-1K (TEF) and of the ribosomal protein S7 (RPS7) for the production of Humicola insolens cellulase II and xylanase I. Constitutive promoters may be problematic when the product being expressed is toxic to the host. Y. lipolytica can grow on hydrophobic substrates such as alkanes, fatty acids and triglycerides. Promoters of genes encoding key enzymes in this pathway were tested for their use as inducible promoters. The promoters of the POX genes, encoding acyl-coenzyme A oxidases (the ¢rst enzyme of the L-oxidation pathway), of the POT1 gene, encoding thiolase (the second enzyme of the L-oxidation pathway), and of the ICL1 gene, encoding isocitrate lyase, were compared [9] .
Five di¡erent promoters have been investigated: TEF1, which is constitutive [3] ; hp4d, which is growth phase-dependent [8] ; and the promoters inducible by peptones (XPR2) [18] , fatty acids (POX2 and ICL1 [10, 19] ) or acetate (ICL1) [19] .
In this paper, we describe a series of tools for heterologous expression in Y. lipolytica : expression/secretion integrative vectors based on an either synthetic or native promoter, markers permitting direct selection of multicopy transformants, and strains designed to improve ease of handling and protein production. This system was used for the production of the Y. lipolytica extracellular lipase LIP2p and of the Aspergillus oryzae leucine amino peptidase II [20] . We will present the production results, with or without gene ampli¢cation, in batch or in fed batch.
Materials and methods

Strains and growth media
Escherichia coli strains used were DH5KFP (Stratagene) and BZ234 FPr 3 m þ Tn10 supD delta(pro lac) (Biozentrum der Universita «t Basel, Basel, Switzerland). They were grown in Luria^Bertani medium at 37 ‡C [21] . When required, ampicillin (80 Wg ml 31 ) or kanamycin (40 Wg ml 31 ) were added. Yeast strains used are shown in Table 1 . The media and techniques used to grow and handle Y. lipolytica were described by Barth and Gaillardin [4] . They were grown in rich medium YPD and YT 2 DH 5 (10 g yeast extract, 20 g bactotryptone N1, 10 g glucose, 50 g olive oil, bu¡ered with 50 mM phosphate bu¡er, pH 6.8) or in de¢ned medium (de¢ned medium for inoculum (DMI), de¢ned medium (DM) and de¢ned medium for fed batch (DMFB)) for fermentation experiments. DMI contained per litre: KH 2 4 H 2 PO 4 , 5 g; glucose, 20 g; trace elements solution, 51 ml; vitamins solution, 17 ml. The end of batch phase was easily detected by a sharp decrease in gas exchange rate (both oxygen consumption and CO 2 production). At that time, culture was fed at a constant rate of 47 g h 31 with a concentrated glucose stock solution of 490 g kg 31 .
Cultivation under controlled conditions
All cultivations were performed at 28 ‡C in 7-l bioreactors (new MBR, Zurich, Switzerland) for batch experiments (working volume of 3 l) and in 15-l bioreactors for fed-batch experiments (6-l working volume). An overpressure of 0.3 bar was applied to the reactor. Dissolved oxygen was continuously monitored with an oxygen probe (Mettler Toledo, Greifensee, Switzerland) and was never below 30% of saturation. Stirrer speed was kept at 7001 000 rpm and air£ow rate was controlled at 3^6 l min 31 by use of a mass £ow meter (Bronkhorst, Ruurlo, The Netherlands). pH was automatically maintained at 5.5 þ 0.05 by addition of 2 N NaOH or 2 N HCl for batch cultivations, and addition of 25% NH 4 OH solution for fed-batch cultivations. In order to avoid excessive foam formation, a level sensor was placed 15 cm from the top Plasmids pINA1269, 1267 and 1296 are pBR322-based mono-copy integrative vectors carrying the LEU2 gene. They can be targeted to the docking platform of Po1e or Po1g strains after NotI digestion. The other plasmids derived from JMP3 or JMP5: they are mono-copy or multi-copy integrative vectors, respectively, carrying the URA3 gene (non-defective ura3d1 allele) or the defective ura3d4 allele. The expression cassette can be liberated by NotI digestion prior to transformation. They could integrate at random in ylT1-free strains Po1d, Po1f or YLP21. They are termed 'auto-cloning' since the integrating expression cassette is devoid of bacterial sequence. All the auto-cloning vectors exist in two versions: those with the ¢rst number are mono-copy (with ura3d1), and those with the second number, between brackets, are multi-copy (with ura3d4).
of the reactor which activated addition of 10 g l 31 antifoam solution (Structol J673, Schill and Seilacher, Hamburg, Germany). O¡-gas was cooled in a condenser and analysed for O 2 and CO 2 molar fraction using Oxymat 5E and Ultramat 5E (Siemens, Zurich, Switzerland), respectively.
Vectors construction
Vectors JMP3, JMP5 and JMP6 (pPOX2 :LIP2 inserted into JMP3) were previously described [10] . Vectors pINA1291^pINA1297 were derived from JMP3 (Table  2) , in which the HindIII site in the polylinker was suppressed by ¢ll-in (JMP3b). The following elements were then inserted successively into the polylinker: (i) a MluIB amHI fragment carrying hp4d, obtained from pINA1269 using PCR, to give the intermediate plasmid pINA1290.
(ii) A KpnI^EcoRI fragment carrying LIP2 terminator, obtained from JMP6 using PCR, to give the pINA1291 expression vector. (iii) A blunt (PmlI compatible)^BamHI fragment carrying LIP2 prepro sequence, obtained from JMP6 using PCR, to give the pINA1293 expression/secretion vector. Similarly, inserted successively into the polylinker from pINA1290 were: (i) the KpnI^EcoRI fragment from pINA1269, carrying the XPR2 terminator, to give the pINA1292 expression vector (Table 2) . (ii) A blunt (PmlI compatible)^KpnI fragment carrying XPR2 prepro sequence, obtained from pINA1267 using PCR, to give the pINA1294 expression/secretion vector. (iii) A blunt (PmlI compatible)^BamHI fragment carrying XPR2 pre sequence, formed by the hybridisation of two oligonucleotides, to give the pINA1297 expression/secretion vector. In order to obtain the vectors pINA1311^pINA1317 ( Fig. 1 and Table 2 ), the MluI^EcoRI fragment from pINA1291p INA1297, corresponding to the expression cassette, was inserted into the polylinker of JMP5, in which the HindIII site was suppressed by ¢ll-in (JMP5b). Vectors JMP61 (JMP63) and JMP62 (JMP64) were obtained by exchange of the ClaI^HindIII and ClaI^BamHI fragment, respectively, from pINA1313 (pINA1293) with a modi¢ed POX2 promoter (pPOX2h and pPOX2b, respectively) obtained from 2pNNH-LacZ plasmid (J.-M. Nicaud, unpublished) using PCR. The HindIII site is located downstream of the ATG, as for pINA1313 (Figs. 1 and 2) ; the BamHI site is located upstream of the ATG in POX2 promoter, by modi¢cation of the sequence 5P-AAGCAACGACGCC.A-TG.AAG.CTT to 5P-AAGCAACGGATCC.
The vector pINA1293-LIP2 was obtained by insertion of a 1-kb HindIII^BamHI fragment carrying LIP2 from JMP6 into pINA1293 at the corresponding sites in the polylinker. The pINA1267-lapA vector was constructed by inserting into pINA1267 polylinker a S¢I^Asp718I (KpnI isoschizomer) fragment carrying lapA, obtained from an A. oryzae TK3 cDNA library in pGEM-T Easy (Promega), using PCR. The pNFF271 vector was derived from pINA1293 as follows : the mutagenic oligonucleotides 5P-CTCCTTCTGAGGCCTCTTCGGCCCAGAAGC-GATTCGG and 5P-CCGAATCGCTTCTGGGCCGAA-GAGGCCTCAGAAGGAG were used to create a new S¢I site in the lipase signal sequence of pINA1293 (S¢I site underlined, with sequence changes in bold type), following the Quickchange1 site-directed mutagenesis protocol (Stratagene). The pNFF271-lapA vector was then constructed by inserting between S¢I and KpnI sites, in pNFF271 polylinker, the 1.9-kb S¢I^ClaI fragment carrying lapA from pINA1267-lapA vector (the KpnI and ClaI sites were blunt-ended, using Klenow DNA polymerase, before ligation). The pNFF331-lapA-His 6 vector was also derived from pNFF271, as follows : ¢rst, pNFF271 was BamHI^Asp718I-digested and a linker composed of the two oligonucleotides 5P-GATCTGGCCACGTGGGCC-GG and 5P-GTACCGGCCCACGTGGCCA was inserted to give the intermediate plasmid pNFF296. This linker creates another S¢I site (in bold type) and a unique PmlI site (underlined). By site-directed mutagenesis on pNFF296, using the two oligonucleotides 5P-CAACCA-CACACATCCATCATGAAGCTTTCCACC and 5P-G-GTGGAAAGCTTCATGATGGATGTGTGTGGTTG, a new RcaI site (underlined^isoschizomer of BspHI) was generated at the ATG sequence of the modi¢ed lipase signal sequence, creating the pNFF331 vector. Then, the two mutagenic oligonucleotides 5P-CCGGCCTCTTCG-GCCGCCAAGCGAGGGAGGGCGCTTGTT and 5P-G-TACCGGCCCACGTGGCCTAGTGGTGGTGGTGGT-GGTGTGCCTCGACTTGAGAATGC were used to synthesise a 1.5-kb PCR fragment from pNFF271-lapA. This fragment created a His-tagged lapA gene (S¢I sites underlined, His-tag in bold type), which was digested with S¢I and inserted between corresponding sites in the pNFF331 polylinker.
Vectors pYEG1 and pYSG1 ( Fig. 1 and Table 2 ) were derived from JMP5b. The following elements were inserted into the polylinker: (i) a ClaI^S¢I fragment carrying POX2 promoter, obtained from a pGEM-pPOX2 plasmid using PCR, and (ii) a S¢I^EcoRI fragment carrying XPR2 terminator, obtained from a JMP5-XPR2t plasmid isolated by PCR, to give the intermediate plasmid pYEG2. The vector pYEG1 was built similarly, but modi¢cations were introduced during PCR, creating the AvrII site upstream of the ATG sequence (see Fig. 2 ). The vector pYSG1 was derived from pYEG2, by inserting into the polylinker a HindIII^SacII fragment carrying LIP2 prepro sequence, obtained from pINA1293 using PCR. Vectors pYEG10 and pYSG10 were derived similarly from JMP3b.
Biochemical methods
Leucine amino peptidase II activity was determined by conversion of H-Leu-p-nitroaniline (Sigma Chemical, Saint Louis, MO, USA) to p-nitroanilide and detection at 400 nm. An 80 mM substrate solution was prepared in absolute ethanol and 50 Wl was diluted in 900 Wl of 100 mM NH 4 Cl bu¡er at pH 7.8. Culture supernatant (50 Wl after appropriate dilution) was added and absorbance was monitored in function of time at 23 ‡C. Leucine amino peptidase activity was expressed as Wmol p-nitroaniline formed per ml sample per min (U ml 31 ), knowing that the extinction coe⁄cient of p-nitroanilide is 10 500 l mol 31 cm 31 . Lipase activity was determined by titrimetric assay as described previously [10] or spectrophotometrically by monitoring hydrolysis of p-nitrophenyl butyrate (pPNB) to p-nitrophenol and butyrate. Reaction bu¡er consisted of 100 mM NaCl in 100 mM NaH 2 PO 4 W2H 2 O, pH 7.2. pPNB was dissolved in absolute ethanol and added to bu¡er to a ¢nal concentration of 1 mM. Absorbance was measured at 405 nm as a function of time after addition of 20 Wl culture supernatant to 980 Wl reaction bu¡er. Lipase activity was expressed as Wmol p-nitrophenol formed per ml sample per min (U ml 31 ) at 23 ‡C, knowing that the extinction coe⁄cient of p-nitrophenol is 15 000 l mol 31 cm 31 . Biomass was monitored either by measuring optical density (OD 600 ) or by dry weight (DW) determination. When cells were grown on media containing oleic acid, samples were extracted with 2/5 volume of propanol/butanol mixture (1:1 v/v) prior to optical density determination.
Results
Y. lipolytica vectors
Replicative vectors containing ARS sequences were used for the production of prochymosin [18] , porcine K-interferon [23] and human coagulation factor XIIIa [24] . However, these vectors are present in only one to three copies per cell. To obtain higher gene dosages, integrative vectors had to be developed. Newly developed Y. lipolytica expression/secretion vectors integrate within the genome by single crossover. They target either to a docking platform [8] , rDNA or zeta regions [25, 26] , or integrate randomly [10] . Fig. 2 . Sequence of the polylinker region in the expression cassette of di¡erent vectors. The sequence of the promoter and terminator is partly shown, in lower-case letters. The cloning sites are shown in upper-case letters. The nucleotide and amino acid sequences of the LIP2 prepro region are partly indicated. When modi¢cations were introduced in this region, the previous sequence is indicated (above the nucleotide sequence or below the amino acid sequence). The ATG sequence and the dipeptide cleavage site LysArg are underlined. In the case of pINA1311, the sequence AATG must be reconstituted during the insertion of the gene of interest at the blunt PmlI upstream cloning site. In the case of respectively pINA1313 and pYSG1, the end of the LIP2 prepro sequence (up to KR) must be reconstituted during the insertion of the gene of interest at respectively XmnI or S¢I upstream cloning site.
Our plasmids are based on pBR322 or pHSS6 vector for replication and selection in E. coli (ampicillin or kanamycin resistance, respectively). They contained (i) as selective marker: either LEU2 or URA3 genes for selection of transformants in yeast. Two URA3 alleles were used: the wild-type ura3d1 allele, resulting in predominantly singlecopy transformants, and a mutant ura3d4 allele, allowing direct selection of multi-copy integrants [10, 25] . (ii) For driving expression: either the synthetic hp4d promoter or the inducible POX2 promoter. (iii) For secretion: the XPR2 or the LIP2 prepro region, and ¢nally the XPR2 or the LIP2 terminator. A non-exhaustive list of the available vectors is presented in Table 2 . Maps of vectors pINA1311, pINA1313, pYEG1 and pYSG1 and their cloning sites are presented in Figs. 1 and 2. 
Lipase production by Y. lipolytica
We previously reported on the overproduction of Y. lipolytica LIP2p by strain JMY184 containing multiple copies of the LIP2 gene expressed under control of the POX2 promoter. In YPDH medium, lipase activity reached 1500 U ml 31 at 60 h after induction [10] . Further improvement was obtained by growing JMY184 in YT 2 DH 5 medium, in which we obtained in shake £asks 11 500 U ml 31 after 160 h induction (Fig. 3A) . We observed the accumulation of a single protein band in the culture supernatant (Fig. 3B) . No lipase production could be observed during the ¢rst 25 h when cells were growing on glucose. When glucose was exhausted and the cells were consuming the olive oil, lipase production initiated (Fig. 3A) .
In order to test lipase production, in de¢ned media under controlled growth conditions, we followed lipase production by strain YPL280 cultivated in a bioreactor. This strain contains multiple copies of the LIP2 coding region under the control of hp4d. Strain YPL280 was derived from strain JMY280 by transformation with plasmid pINA1267, rendering it leucine-prototrophic. Fermenters were inoculated with cells pregrown in DMI medium. Biomass and lipase accumulation were monitored during 100 h in batch and fed-batch cultures (Fig. 4) . In batch cultures on DM, most of the lipase production occurred during stationary phase (Fig. 4A) . Lipase activity reached 11 500 U ml 31 after 70 h of stationary phase. Silver-stained gel revealed a strong single band at 39 kDa, corresponding to lipase (data not shown). Thus lipase was the major secreted protein. During fed-batch cultivations on glucose, lipase activity reached 90 500 U ml 31 after about 70 h of feeding, with a ¢nal biomass concentration of 80 g DW l 31 (Fig. 4B) . These results showed that similar lipase production could be obtained with POX2 promoter and hp4d. However, with POX2 promoter, production occurred during growth phase on oleic acid, while with hp4d, production occurred during stationary phase. In conclusion, fed-batch cultivation mode resulted in a 7.9-fold increase of lipase production after 100 h, compared to batch cultivation.
Production of A. oryzae leucine amino peptidase II by Y. lipolytica
We tested our expression system for the production of heterologous proteins using the A. oryzae leucine amino peptidase II as a model. The e¡ect of gene ampli¢cation on LapAp production under control of hp4d promoter was investigated in batch experiments (Fig. 5A,B) . Cells were grown in DM and pH was maintained at 5.5. Both for YT3655, a single integrant, and YT3824, a multiple integrant, LapAp production started after 22 h growth, when cells entered in stationary phase once growth had stopped due to glucose exhaustion (Fig. 5A,B) . The LapAp accumulation was linear with time for more than 30 h.
During the production phase, the speci¢c LapAp production rate was 1.29 U mg 31 h 31 for YT3655 (Fig. 5A ). By comparison, the speci¢c production rate was 9.89 U mg 31 h 31 for YT3824 (Fig. 5B) , which corresponds to a 7.7-fold increase due to gene ampli¢cation. The corresponding total amounts of leucine amino peptidase activity were, respectively, 320 mU ml 31 (Fig. 5A ) and 2500 mU ml 31 (Fig. 5B) , which corresponds to an eight-fold increase. These ampli¢cation factors are similar to those obtained for the lipase [10] or for the L-galactosidase [26] , using a ura3d4 defective marker. Strain YT4236 (a multi- copy integrant expressing a His-tagged LapAp) was cultivated in fed-batch mode with a constant glucose feed at 47 g h 31 after the batch phase. Dissolved oxygen remained above 30% of saturation throughout the feeding phase.
After 48 h of feeding, the biomass concentration reached 61 g l 31 (Fig. 5C ). The average speci¢c productivity was 12.1 U mg 31 h 31 . The ¢nal leucine amino peptidase activity was 28 000 mU ml 31 (Fig. 5C) , that is 11 times higher in fed batch than in batch for comparable experiment duration. Considered together, these results showed that an 88-fold increase in LapAp production was reached between a single-copy integrant (YT3655) grown in batch and a multi-copy integrant (YT4236) grown in fed batch.
Discussion
We presented above a series of tools for heterologous expression in Y. lipolytica. Vectors and host strains were designed for easy handling and performance. Strains Po1f, YLP21 and Po1g are devoid of secreted protease activity, are able to grow on sucrose or molasses, and allow the easy integration of a targeted pBR-based vector (for the latter) or of bacterial sequence-free expression cassettes, at random (for the two others). The resulting producing strain is, or can be easily rendered, prototroph, ensuring an optimal growth.
We described a series of expression/secretion vectors combining a choice of elements: (i) either XPR2 or LIP2 targeting sequence, which were both used successfully in the described examples; (ii) either hp4d or POX2 promoter ; (iii) either XPR2 or LIP2 terminator ; (iv) either LEU2 or URA3 (wild-type or mutant) marker. We presented examples of the utilisation of both promoters, which appear to be complementary: the synthetic hp4d can be used in virtually any medium, and is growth phase-dependent, the production starting at the entry into stationary phase; in contrast, with the inducible POX2 promoter, the production occurs during the growth phase on oleic acid. Our results with lipase show that a similar production can be obtained with both promoters.
Lipase production under the control of the hp4d promoter by a strain containing a single copy was previously found to reach 1000 U ml 31 in shake £ask, while a strain containing multiple integrations reached 2000 U ml 31 in shake £ask [10] . We showed above that the production of this later strain could reach 11 500 U ml 31 in batch and 90 500 U ml 31 in fed batch : the combined e¡ects of gene ampli¢cation and fed-batch cultivation thus permitted to increase production by nearby two orders of magnitude (91 times).
We tested our expression system for the production of heterologous proteins, using the A. oryzae LapAp as a model. The e¡ect of gene ampli¢cation can be seen by comparison of LapAp production, in batch, by YT3824 (multi-copy pNFF271-lapA vector in Po1f) and by YT3655 (mono-copy pINA1267-lapA vector in Po1g) strains: it was an eight-fold increase, in agreement with previous results [10, 25] . The production in fed batch of strain YT4236 (multi-copy pNFF331-lapA-His 6 vector in YLP21) was still 11-fold higher. Thus, an 88-fold (or almost two orders of magnitude) increase in productivity was observed between a single-copy integrant grown in batch and a multi-copy integrant grown in fed batch.
The results obtained with either a cognate (lipase) or a heterologous protein (A. oryzae leucine amino peptidase II) validate our Y. lipolytica expression/secretion system. We wish to emphasise that, despite the fact that growth conditions and media composition were not optimised, the combined e¡ects of gene ampli¢cation using a mutant allele marker, and fed-batch cultivation permitted to increase the production almost 100 times.
